|
| 36063397 | Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022). | Clin Infect Dis | 2024 |
| 37897218 | Understanding clinical implementation coordinators' experiences in deploying evidence-based interventions. | Am J Health Syst Pharm | 2024 |
| 36162605 | Surgical site infections during the COVID-19 era: A retrospective, multicenter analysis. | Am J Infect Control | 2023 |
| 37882516 | Genomic epidemiology reveals the dominance of Hennepin County in the transmission of SARS-CoV-2 in Minnesota from 2020 to 2022. | mSphere | 2023 |
| 38040756 | COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients. | Sci Rep | 2023 |
| 37674635 | The Diagnostic Accuracy of Metagenomic Next-Generation Sequencing in Diagnosing <i>Pneumocystis</i> Pneumonia: A Systemic Review and Meta-analysis. | Open Forum Infect Dis | 2023 |
| 37760749 | Bloodstream Infection Due to Coagulase-Negative Staphylococci: Impact of Species on Prevalence of Infective Endocarditis. | Antibiotics (Basel) | 2023 |
| 35698452 | Rebound Phenomenon After Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease 2019 (COVID-19) in High-Risk Persons. | Clin Infect Dis | 2023 |
| 35776382 | Diagnostic delay in pulmonary blastomycosis: a case series reflecting a referral center experience. | Infection | 2023 |
| 37125977 | Supportive Care Management Recommendations for Mucocutaneous Manifestations of Monkeypox Infection. | Mayo Clin Proc | 2023 |
| 37286960 | Body temperature and infection in critically ill patients on continuous kidney replacement therapy. | BMC Nephrol | 2023 |
| 37007579 | Septic shock definitions and associated outcomes in blood culture positive critically ill patients. | Ann Transl Med | 2023 |
| 36963910 | Paediatric safety assessment of BNT162b2 vaccination in a multistate hospital-based electronic health record system in the USA: a retrospective analysis. | Lancet Digit Health | 2023 |
| 37093599 | Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes. | JAMA Netw Open | 2023 |
| 36751645 | Comparing Complication Rates of Midline Catheter vs Peripherally Inserted Central Catheter. A Systematic Review and Meta-analysis. | Open Forum Infect Dis | 2023 |
| 36644593 | Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening Score. | Mayo Clin Proc Innov Qual Outcomes | 2023 |
| 36737113 | Integrating Infectious Diseases and Preventive Medicine Specialties Into 1 Division: Experience of an Academic Medical Center. | Mayo Clin Proc | 2023 |
| 36604461 | Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants. | Sci Rep | 2023 |
| 36707188 | Multiomics single timepoint measurements to predict severe COVID-19 - Authors' reply. | Lancet Digit Health | 2023 |
| 34247662 | Increased rates of blood culture contamination during the coronavirus disease 2019 pandemic. | Infect Control Hosp Epidemiol | 2022 |
| 35799373 | Outcomes of Mayo Clinic reBoot camps for postimplementation training in the electronic health record. | J Am Med Inform Assoc | 2022 |
| 35673245 | COVID-19 Infections in Health Care Personnel by Source of Exposure and Correlation With Community Incidence. | J Occup Environ Med | 2022 |
| 35835712 | Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study. | Lancet Digit Health | 2022 |
| 35791358 | Outcomes of B-Cell-Depleted Patients With Coronavirus Disease 2019 Treated With Antispike Monoclonal Antibodies. | Open Forum Infect Dis | 2022 |
| 35667076 | In patients with COVID-19 receiving IMV or ECMO, adding baricitinib to usual care reduced all-cause mortality. | Ann Intern Med | 2022 |
| 35420661 | Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records. | JAMA Netw Open | 2022 |
| 35860600 | SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes. | PNAS Nexus | 2022 |
| 35512884 | Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019. | Mayo Clin Proc | 2022 |
| 35512874 | Impact of the COVID-19 Pandemic on Respiratory Infection Rates. | Mayo Clin Proc | 2022 |
| 35848574 | Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch. | Transpl Infect Dis | 2022 |
| 36713312 | Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection. | PNAS Nexus | 2022 |
| 36713311 | Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19. | PNAS Nexus | 2022 |
| 36523407 | Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditions. | medRxiv | 2022 |
| 36213724 | Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron Epoch. | Open Forum Infect Dis | 2022 |
| 36310773 | Overview and risk factors for postcraniotomy surgical site infection: A four-year experience. | Antimicrob Steward Healthc Epidemiol | 2022 |
| 35969000 | Outcomes of Solid Organ Transplant Recipients Treated With Antispike Monoclonal Antibodies for Coronavirus Disease 2019 Across Variant Epochs: Impact of Comorbidities and Vaccination. | Transplantation | 2022 |
| 36061125 | Predictors of Treatment Failure in Patients With Pyogenic Brain Abscess. | World Neurosurg X | 2022 |
| 36058578 | Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019. | Mayo Clin Proc | 2022 |
| 36124696 | Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients With Coronavirus Disease-2019 During Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 Omicron Epoch. | J Infect Dis | 2022 |
| 36286008 | Imported Haycocknema perplexum Infection, United States<sup>1</sup>. | Emerg Infect Dis | 2022 |
| 33557991 | Evaluation of an initiative to improve prophylactic antimicrobial prescribing in patients on extracorporeal membrane oxygenation (ECMO) through the application of three antimicrobial-spectrum scores. | Infect Control Hosp Epidemiol | 2022 |
| 35068257 | Utilization of an Electronic Health Record Integrated Risk Score to Predict Hospitalization Among COVID-19 Patients. | J Prim Care Community Health | 2022 |
| 35120695 | Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant. | Mayo Clin Proc | 2022 |
| 34902581 | Diagnosis, management, and outcomes of brain abscess due to gram-negative versus gram-positive bacteria. | Int J Infect Dis | 2022 |
| 34927113 | Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection. | Med | 2022 |
| 34668010 | Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords. | Clin Infect Dis | 2022 |
| 34668008 | Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel. | Clin Infect Dis | 2022 |
| 32703323 | Antimicrobial prescribing practices at a tertiary-care center in patients diagnosed with COVID-19 across the continuum of care. | Infect Control Hosp Epidemiol | 2021 |
| 33855101 | Clinical Presentation, Management, and Outcomes of Patients With Brain Abscess due to <i>Nocardia</i> Species. | Open Forum Infect Dis | 2021 |
| 33575744 | Reducing Broad-Spectrum Antimicrobial Use in Extracorporeal Membrane Oxygenation: Reduce AMMO Study. | Clin Infect Dis | 2021 |